StoxSun Pharmaceutical Industries vs Dr. Reddy's Laboratories: share price & financials comparison
NSE: SUNPHARMA vs DRREDDY · Healthcare · as of 13 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Sun Pharmaceutical Industries vs Dr. Reddy's Laboratories at a glance
Sun Pharmaceutical Industries (SUNPHARMA) has a market capitalisation of ₹4,51,068 Cr, against ₹1,15,230 Cr for Dr. Reddy's Laboratories (DRREDDY). Over the past year Dr. Reddy's Laboratories has returned +15.0%, compared with +11.2% for Sun Pharmaceutical Industries. On valuation, Sun Pharmaceutical Industries trades at a lower P/E of 41.1 versus 41.2. Sun Pharmaceutical Industries earns a higher return on equity (12.3% vs 7.2%). Sun Pharmaceutical Industries comes out ahead on size, valuation, profitability and financial health. Dr. Reddy's Laboratories comes out ahead on growth and technicals. Across the scored metrics below, Sun Pharmaceutical Industries leads on 11 and Dr. Reddy's Laboratories on 7. On StoxGud's 10-point checklist, Sun Pharmaceutical Industries scores 8/10 and Dr. Reddy's Laboratories scores 5/10.
| Metric | Sun Pharmaceutical Industries | Dr. Reddy's Laboratories |
|---|---|---|
| Size | ||
| Market cap | ₹4,51,068 Cr | ₹1,15,230 Cr |
| Revenue (latest FY) | ₹58,462 Cr | ₹33,700 Cr |
| Net profit (latest FY) | ₹11,479 Cr | ₹4,196 Cr |
| Valuation | ||
| P/E | 41.1 | 41.2 |
| P/B | 5.05 | 2.97 |
| Dividend yield | 0.87% | 0.58% |
| Profitability | ||
| Return on equity | 12.3% | 7.2% |
| Net profit margin | 17.8% | 8.5% |
| Operating margin | 29.3% | 14.7% |
| Growth | ||
| Revenue growth (YoY) | +11.9% | -1.5% |
| Net profit growth (YoY) | -36.2% | -31.3% |
| Revenue CAGR (multi-year) | +11.8% | +12.1% |
| Financial health | ||
| Debt to equity | 0.03 | 0.15 |
| Momentum | ||
| 1-month return | +6.2% | +11.3% |
| 1-year return | +11.2% | +15.0% |
| 3-year CAGR | +16.9% | +8.4% |
| 5-year CAGR | +18.3% | +7.2% |
| 10-year CAGR | +10.7% | +7.6% |
| Distance from 52W high | -6.1% | -0.5% |
| Technicals | ||
| RSI (14) | 81 | 85 |
| Price vs 200-day avg | +3.6% | +10.1% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Sun Pharmaceutical Industries | Dr. Reddy's Laboratories |
|---|---|---|
| Price above 50-day average | ✓ | ✓ |
| Price above 200-day average | ✓ | ✓ |
| 50-day average above 200-day (uptrend) | ✓ | ✗ |
| RSI in healthy 40–70 zone | ✗ | ✗ |
| Positive 1-year return | ✓ | ✓ |
| Return on equity above 15% | ✗ | ✗ |
| Debt to equity below 1 | ✓ | ✓ |
| Revenue growing year on year | ✓ | ✗ |
| Net profit margin above 10% | ✓ | ✗ |
| P/E below industry median | ✓ | ✓ |
| Score | 8/10 | 5/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Sun Pharmaceutical Industries or Dr. Reddy's Laboratories?
Sun Pharmaceutical Industries has a market cap of ₹4,51,068 Cr and Dr. Reddy's Laboratories has a market cap of ₹1,15,230 Cr as of 13 Nov 2026.
Which has a lower P/E, Sun Pharmaceutical Industries or Dr. Reddy's Laboratories?
Sun Pharmaceutical Industries has the lower P/E: Sun Pharmaceutical Industries trades at 41.1 and Dr. Reddy's Laboratories at 41.2.
Which gave better returns in the last year, Sun Pharmaceutical Industries or Dr. Reddy's Laboratories?
Dr. Reddy's Laboratories did better: Sun Pharmaceutical Industries returned +11.2% and Dr. Reddy's Laboratories returned +15.0% over one year.
What is the difference between Sun Pharmaceutical Industries and Dr. Reddy's Laboratories?
Both are NSE-listed companies in Healthcare. Sun Pharmaceutical Industries is about 3.9 times the size of Dr. Reddy's Laboratories by market cap. In the latest financial year Sun Pharmaceutical Industries reported revenue of ₹58,462 Cr and Dr. Reddy's Laboratories ₹33,700 Cr. Operating margin is 29.3% for Sun Pharmaceutical Industries and 14.7% for Dr. Reddy's Laboratories. Debt to equity is 0.03 for Sun Pharmaceutical Industries and 0.15 for Dr. Reddy's Laboratories.
Which is better, Sun Pharmaceutical Industries or Dr. Reddy's Laboratories?
It depends on what you are looking for, and StoxGud does not recommend either stock. On the metrics compared above, Sun Pharmaceutical Industries leads on 11 and Dr. Reddy's Laboratories on 7. Sun Pharmaceutical Industries is ahead on size, valuation, profitability and financial health. Dr. Reddy's Laboratories is ahead on growth and technicals. On StoxGud's rules-based checklist Sun Pharmaceutical Industries scores 8/10 and Dr. Reddy's Laboratories scores 5/10. This is information, not advice: consult a SEBI-registered adviser before investing.